Cargando…
Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant
Diabetic macular edema (DME) is the leading cause of sight-threatening complication in diabetic patients, and several treatment modalities have been developed and evaluated to treat this pathology. Intravitreal agents, such as anti-vascular endothelial growth factors (anti-VEGF) or corticosteroids,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655951/ https://www.ncbi.nlm.nih.gov/pubmed/26604809 http://dx.doi.org/10.2147/DMSO.S73540 |